Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 30:2:35.
doi: 10.3389/fendo.2011.00035. eCollection 2011.

Male/Female differences in neuroprotection and neuromodulation of brain dopamine

Mélanie Bourque  1 , Dean E Dluzen, Thérèse Di Paolo
Affiliations

Male/Female differences in neuroprotection and neuromodulation of brain dopamine

Mélanie Bourque et al. Front Endocrinol (Lausanne). .

Abstract

The existence of a sex difference in Parkinson's disease (PD) is observed as related to several variables, including susceptibility of the disease, age at onset, and symptoms. These differences between men and women represent a significant characteristic of PD, which suggest that estrogens may exert beneficial effects against the development and the progression of the disease. This paper reviews the neuroprotective and neuromodulator effects of 17β-estradiol and progesterone as compared to androgens in the nigrostriatal dopaminergic (NSDA) system of both female and male rodents. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mice model of PD and methamphetamine toxicity faithfully reproduce the sex differences of PD in that endogenous estrogen levels appear to influence the vulnerability to toxins targeting the NSDA system. Exogenous 17β-estradiol and/or progesterone treatments show neuroprotective properties against NSDA toxins while androgens fail to induce any beneficial effect. Sex steroid treatments show male and female differences in their neuroprotective action against methamphetamine toxicity. NSDA structure and function, as well as the distribution of estrogen receptors, show sex differences and may influence the susceptibility to the toxins and the response to sex steroids. Genomic and non-genomic actions of 17β-estradiol converge to promote survival factors and the presence of both estrogen receptors α and β are critical to 17β-estradiol neuroprotective action against MPTP toxicity.

Keywords: 17β-estradiol; MPTP; androgens; dopamine; methamphetamine; neuromodulation; neuroprotection; sex difference.

PubMed Disclaimer

References

    1. Abraham I. M., Herbison A. E. (2005). Major sex differences in non-genomic estrogen actions on intracellular signaling in mouse brain in vivo. Neuroscience 131, 945–951 - PubMed
    1. Al-Sweidi S., Morissette M., Bourque M., Di Paolo T. (2011). Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson’s disease. Neuropharmacology 61, 583–59110.1016/j.neuropharm.2011.04.031 - DOI - PubMed
    1. Alyea R. A., Laurence S. E., Kim S. H., Katzenellenbogen B. S., Katzenellenbogen J. A., Watson C. S. (2008). The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J. Neurochem. 106, 1525–153310.1111/j.1471-4159.2008.05491.x - DOI - PMC - PubMed
    1. Alyea R. A., Watson C. S. (2009). Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux. BMC Neurosci. 10, 59.10.1186/1471-2202-10-59 - DOI - PMC - PubMed
    1. Anderson L. I., Leipheimer R. E., Dluzen D. E. (2005). Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice. Neuroscience 130, 369–38210.1016/j.neuroscience.2004.09.033 - DOI - PubMed

LinkOut - more resources